Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Gutierrez Ibarluzea I"'
Autor:
Luján, M., Peñuelas, Ó., Cinesi Gómez, C., García-Salido, A., Moreno Hernando, J., Romero Berrocal, A., Gutiérrez Ibarluzea, I., Masa Jiménez, J.F., Mas, A., Carratalá Perales, J.M., Gaboli, M., Concheiro Guisán, A., García Fernández, J., Escámez, J., Parrilla Parrilla, J., Farrero Muñoz, E., González, M., Heili-Frades, S.B., Sánchez Quiroga, M.Á., Rialp Cervera, G., Hernández, G., Sánchez Torres, A., Uña, R., Ortolà, C.F., Ferrer Monreal, M., Egea Santaolalla, C.
Publikováno v:
In Medicina Intensiva (English Edition) June-July 2021 45(5):298-312
Autor:
Otte M; OITBpathway V. o. G, Eupen, Belgium., Dauben HP; OITBpathway V. o. G, Eupen, Belgium., Ahn J; Department of Health Convergence, Ewha Womans University, Seoul, South Korea., Gutierrez Ibarluzea I; Health ClusterNET, Amsterdam, Netherlands., Drummond M; Centre for Health Economics, University of York, York, UK., Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary., Suh DC; Korea Institute for Pharmaceutical Policy Affairs, Seoul, South Korea.
Publikováno v:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Nov; Vol. 24 (9), pp. 1061-1066. Date of Electronic Publication: 2024 Sep 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hogervorst, M.A., Vreman, R., Heikkinen, I., Bagchi, I., Gutierrez-Ibarluzea, I., Ryll, B., Eichler, H.G., Petelos, E., Tunis, S., Sapede, C., Goettsch, W., Janssens, R., Huys, I., Barbier, L., DeJean, D., Strammiello, V., Lingri, D., Goodall, M., Papadaki, M., Toussi, M., Voulgaraki, D., Mitan, A., Oortwijn, W.J.
Publikováno v:
International Journal of Technology Assessment in Health Care, 39, 1
Contains fulltext : 294548.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Uncertainty is a fundamental component of decision making regarding access to and pricing and reimbursement of drugs. The context-specific interpretation and mitigation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1236::4e3ef9a989b55c5d9d5a75b2376b0e27
https://repository.ubn.ru.nl/handle/2066/294548
https://repository.ubn.ru.nl/handle/2066/294548
Autor:
Spanish National Task Force on Public Health Genomics, Gutiérrez-Ibarluzea, I., Ibarreta, D., Malats, N.
Publikováno v:
Public Health Genomics, 2012 Jan 01. 15(6), 313-321.
Externí odkaz:
https://www.jstor.org/stable/26686620
Autor:
Refolo, Pietro, Sacchini, Dario, Bloemen, B, Grin, J, Gutierrez-Ibarluzea, I, Hofmann, B, Oortwijn, W, Sampietro-Colom, L, Sandman, L, van der Wilt GW, Spagnolo, Antonio Gioacchino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2601::cc49875b9d25f9c513ad168296aa8dab
http://hdl.handle.net/10807/217690
http://hdl.handle.net/10807/217690
Autor:
Jakab I; Syreon Research Institute, Budapest, Hungary.; Patient advocate, Budapest, Hungary., Dimitrova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Bereczky T; Patvocates GmbH, Riemerling, Germany., Fövényes M; Lymfoma Slovensko, Bratislava, Slovakia., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Belina I; Coalition of Associations in Healthcare, Zagreb, Croatia., Andriciuc C; Romanian Federation of Diabetes Associations, Cluj Napoca, Romania., Tóth K; Syreon Research Institute, Budapest, Hungary.; Bridge of Health Alliance against Breast Cancer Association, Budapest, Hungary., Piniazhko O; Health Technology Assessment Department of State Expert Centre, Ministry of Health of Ukraine, Kyiv, Ukraine., Hren R; Syreon Research Institute, Budapest, Hungary.; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Gutierrez-Ibarluzea I; Basque Foundation for Health Innovation and Research, Landa, Spain., Czech M; Head of Pharmacoeconomic Department, Institute of Mother and Child, Warsaw, Poland., Tesar T; Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia., Niewada M; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; Department of Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, Romania., Kamusheva M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Manova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Savova A; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Mitkova Z; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Dawoud D; Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, United Kingdom., Delnoij D; National Health Care Institute (ZIN), Diemen, Netherlands., Knies S; National Health Care Institute (ZIN), Diemen, Netherlands., Goettsch W; National Health Care Institute (ZIN), Diemen, Netherlands.; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
Publikováno v:
Frontiers in public health [Front Public Health] 2023 Jul 03; Vol. 11, pp. 1176200. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).
Autor:
Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands., Vreman R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Heikkinen I; Global Regulatory Policy, MSD, Copenhagen, Denmark., Bagchi I; Global Pricing & Market Access, GSK, Philadelphia, PA, USA., Gutierrez-Ibarluzea I; Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain.; Basque Office for Health Technology Assessment, Osteba, Barakaldo, Spain., Ryll B; Melanoma Patient Network Europe, Uppsala, Sweden., Eichler HG; Association of Austrian Social Insurance Bodies, Vienna, Austria., Petelos E; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.; Health and Society Lab, Faculty of Medicine, University of Crete, Heraklion, Greece., Tunis S; Center for Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA., Sapede C; Global Public Affairs, Novartis, Basel, Switzerland., Goettsch W; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands., Janssens R; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Huys I; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Barbier L; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., DeJean D; Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada., Strammiello V; European Patients' Forum, Brussels, Belgium., Lingri D; European Healthcare Fraud and Corruption Network - EHFCN, Brussels, Belgium.; Aristotle University of Thessaloniki, Thessaloniki, Greece., Goodall M; Regulatory Affairs International, MSD (UK) Limited, London, UK., Papadaki M; Regulatory Affairs International, MSD (UK) Limited, London, UK., Toussi M; Real World Evidence Solutions, IQVIA, Courbevoie, France., Voulgaraki D; Medtronic Ltd, Watford, UK.; Maastricht University, Maastricht, The Netherlands., Mitan A; DIA, Basel, Switzerland., Oortwijn W; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.; Health Technology Assessment International (HTAi), Edmonton, AB, Canada.
Publikováno v:
International journal of technology assessment in health care [Int J Technol Assess Health Care] 2023 Jun 16; Vol. 39 (1), pp. e40. Date of Electronic Publication: 2023 Jun 16.
Autor:
Zemplényi A; Center for Health Technology Assessment and Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.; Syreon Research Institute, Budapest, Hungary., Tachkov K; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Balkanyi L; Medical Informatics R&D Center, Pannon University, Veszprém, Hungary., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary., Petrova G; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Dawoud D; Science Policy and Research Programme, Science Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), London, United Kingdom.; Cairo University, Faculty of Pharmacy, Cairo, Egypt., Goettsch W; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands.; National Health Care Institute, Diemen, Netherlands., Gutierrez Ibarluzea I; Basque Foundation for Health Innovation and Research, Barakaldo, Spain., Hren R; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Knies S; National Health Care Institute, Diemen, Netherlands., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; G. E. Palade University of Medicine, Pharmacy, Science and Technology, Tirgu Mures, Romania., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Piniazhko O; HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine., Savova A; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council of Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria., Manova M; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council of Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria., Tesar T; Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia., Zerovnik S; Ministry of Health, Ljubljana, Slovenia., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
Publikováno v:
Frontiers in public health [Front Public Health] 2023 Apr 26; Vol. 11, pp. 1088121. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).
Publikováno v:
GMS Health Innovations and Technologies
GMS Health Innovation and Technologies; VOL: 15; DOC01 /20190924/
GMS Health Innovation and Technologies; VOL: 15; DOC01 /20190924/
[for full text, please go to the a.m. URL]
GMS Health Innovation and Technologies; 15:Doc01
GMS Health Innovation and Technologies; 15:Doc01
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6575b91b09cb35134a87c198221280